New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 15, 2013
06:03 EDTGENEGenetic Technologies provides U.S. patent re-examination update
Genetic Technologies announced that the USPTO has now issued an action reaffirming the validity of certain claims contained in the Company's U.S. Patent No. 5,612,179 directed to non-coding DNA. As announced by the Company on July 9, 2012, Genetic Technologies had received formal notification from the USPTO that it had received and granted a request for ex parte re-examination of claims 1-18 and 26-32 of the '179 patent based upon a submission by Merial of Duluth, Georgia. Merial is currently a defendant in an action originally brought by the company in Colorado, USA for infringement of the '179 patent. That action currently is pending in Delaware Federal District Court.
News For GENE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
05:31 EDTGENEGenetic Technologies appoints Eutillio Buccilli as CEO
Genetic Technologies advised that Eutillio Buccilli has been appointed CEO of the company following the resignation of Alison Mew which was effective 31 December 2014. Buccilli joined the company in June 2014 as the Chief Financial Officer and was appointed to the position of COO and CFO in late 2014.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use